Abstract
The present study investigates the linguistic mechanisms employed in pharmaceutical advertising discourse to manipulate mass consciousness. Through a comprehensive analysis of contemporary English-language medical advertisements, the research identifies and categorizes key manipulative techniques, including medicalization, semantic elevation, grammatical de-agentivization, and lifestyle baiting. Drawing on established frameworks from rhetoric, sociolinguistics, and critical discourse analysis, the article examines how language-level devices - such as denominal verb formation, modal auxiliaries, person-shifting pronouns, and abstract nominalizations - serve to construct persuasive narratives that align patient identity with pharmaceutical consumption. The findings reveal that medical advertising systematically exploits epistemic vulnerability and health anxiety, relying on the fusion of scientific authority and emotional resonance.References
1. Conrad, P. (2007). The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Johns Hopkins University Press.
2. Damirovna, E. S. (2025). Sociolinguistic and Cognitive Characteristics of Language in Modern Advertising Discourse. SHOKH Library, 3(1), 45-51.
3. Damirovna, E. S. (2026). Cognitive Mechanisms of Media Discourse: Framing, Conceptualization, and Meaning Construction. Qo’qon DPI Ilmiy Xabarlar Jurnali, 1, 15-22.
4. Egamberdieva, F. O., et al. (2020). Advertising Message as an Object of Pragmatic Research in Linguistics. International Journal on Integrated Education, 3(8), 1124-1130.
5. Egamberdieva, S. (2024). The analysis of language of advertising discourse based on English advertising texts. ACTA NUUz, 5, 112-118.
6. Egamberdieva, S. (2025). Linguopragmatic Features of Advertising Translation. Proceedings of the International Conference on Linguistics Translation, UniConFlix, 78-82.
7. Fairclough, N. (1992). Discourse and Social Change. Polity Press.
8. Halliday, M. A. K. (1994). An Introduction to Functional Grammar (2nd ed.). Edward Arnold.
9. Pichichero, M. E. (2014). Challenges in clinical trial design for antibiotics. Clinical Infectious Diseases, 59(Suppl 3), S119-S121.
10. Polonsky, V. V. (1993). Katastrofa v pustyne [Disaster in the Desert]. Gorizont.

This work is licensed under a Creative Commons Attribution 4.0 International License.